Cannabis Extraction Company Ayurcann To Merge With Arogo, Resulting In $210M Entity
Cannabis Extraction Company Ayurcann To Merge With Arogo, Resulting In $210M Entity
Canadian cannabis extraction company Ayurcann Holdings Corp. (CSE:AYUR) (OTCQB:AYURF) (FSE: 3ZQ0) and a special purpose acquisition company Arogo Capital Acquisition Corporation (NASDAQ:AOGO) entered into a definitive business combination agreement. The combined company will be worth $210 million.
加拿大大麻提取公司Ayurcann Holdings corp. （CSE:AYUR）（OTCQB:AYURF）（FSE: 3ZQ0）和一家特殊目的收購公司Arogo Capital Acquisition Corporation（NASDAQ:AOGO）已簽訂了一項明確的業務合併協議。合併後的公司將價值2.1億美元。
"Ayurcann is one of the most innovative companies we have encountered, particularly in cannabis extraction and product development," stated Suradech Taweesaengsakulthai, CEO and director of Arogo. "With their impressive achievements and forward-looking plans, this business combination is set to drive the business onto a new growth trajectory, enhancing its capabilities and expanding the market reach in meaningful ways."
“Ayurcann是我們遇到的最創新的公司之一，特別是在大麻提取和產品開發方面，” Arogo的首席執行官兼董事Suradech Taweesaengsakulthai表示。“憑藉他們卓越的成就和前瞻性的計劃，這項業務合併將推動業務進入新的增長軌跡，增強其能力並以有意義的方式擴大市場覆蓋面。”
Miami, Florida and Toronto, Canada-based cannabis company highlighted 100% year-over-year growth of gross revenue over the last three audited financial reporting years.
總部位於佛羅里達州邁阿密和加拿大多倫多的大麻公司強調，過去三個審核財務報告年度內營業收入同比增長了100%。
Marijuana Extraction Company Ayurcann Reports 127.7% YoY Revenue Growth For The Third Quarter
大麻提取公司Ayurcann報告第三季度營業收入同比增長127.7%
"We are proud of our team for what we have achieved as a company," Igal Sudman, chief executive officer of Ayurcann stated. "The business combination with Arogo, is our next step in growing the company nationally while allowing us to also look for international opportunities."
“我們爲公司取得的成就感到自豪，” Ayurcann首席執行官Igal Sudman說。“與Arogo的業務合併是我們在全國範圍內發展公司並在尋找國際機遇的下一步。”
Merger Highlights
合併亮點
Under the deal, Ayurcann will pay Arogo $19.6 million in cash. At the same time, it is expected that Ayrucann shareholders will benefit from "an implied pro forma enterprise value of approximately $210 million, at a price of $10.00 per share."
根據交易，Ayurcann將以1960萬美元的現金支付Arogo。同時，預計Ayrucann股東將從“每股10美元的價格，獲得約2.1億美元的預示企業價值”。
The transaction is expected to close in the second half of 2024, subject to the receipt of all regulators, court, shareholders and other approvals, and the satisfaction or waiver of all customary closing conditions.
預計該交易將於2024年下半年完成，需要獲得所有監管機構，法院，股東和其他批准，並滿足或放棄所有慣例的收盤條件。
Under the transaction, ARC Group Limited will receive finder's fees in the amount of 799,731 common shares of the company.
根據該交易，ARC Group Limited將獲得公司的79.9731萬股普通股的發現費用。
Currently there are 194.7 million Ayurcann shares. Upon the transaction, the company projects that 260 million shares will be issued and outstanding, which will be consolidated on a 10:1 ratio, resulting in around 26 million shares.
目前有1.947億股Ayurcann股票。交易後，公司預計將發行並流通2.6億股股票，按比例合併爲約2600萬股。
Canadian Cannabis Companies Could See Valuations Soar By Up To 300% With Tax Reform, New Report Shows
新報告顯示，隨着稅制改革，加拿大大麻公司的估值可能飆升高達300%
Photo: Courtesy of Pasuwan via Shutterstock
照片：由Pasuwan通過shutterstock提供